本文源自：金融界 作者：情报员 专利摘要显示，本公开是关于一种校正电路、充电电路、电源适配器、电源模组及电子设备，所述校正 电路连接于电源与功率输出模块之间，所述校正电路包括：与所述电源相连的第一端和与所述功率输出 模块相连的第二端；整流桥，设置于所述第一端和所述第二端之间；第一校正模块，所述第一校正模块 设置于所述整流桥和所述第一端之间，所述第一校正模块包括第一校正件和第二校正件，其中，所述第 一校正件和所述第二校正件用于过滤不同频次的电流谐波。本公开通过在整流桥和第一端之间设置有第 一校正模块来校正输入至校正电路的电流波形，并通过第一校正件和第二校正件分别校正平滑并吸收不 同频次的电流谐波，以降低电流畸变的影响，并提升无源校正电路的输出功率。 天眼查资料显示，北京小米移动软件有限公司，成立于2012年，位于北京市，是一家以从事软件和信息 技术服务业为主的企业。企业注册资本148800万人民币。通过天眼查大数据分析，北京小米移动软件有 限公司共对外投资了3家企业，参与招投标项目129次，专利信息5000条，此外企业还拥有行政许可123 个。 金融界2025年5月24日消息，国家知识产权局信息显示，北京小米移 ...

天眼查资料显示，中国邮政储蓄银行股份有限公司，成立于2007年，位于北京市，是一家以从事货币金 融服务为主的企业。企业注册资本9916107.6038万人民币。通过天眼查大数据分析，中国邮政储蓄银行 股份有限公司共对外投资了7家企业，参与招投标项目5000次，财产线索方面有商标信息1214条，专利 信息822条，此外企业还拥有行政许可96个。 金融界2025年5月23日消息，国家知识产权局信息显示，中国邮政储蓄银行股份有限公司申请一项名 为"搜索软件的测试方法、装置和搜查软件测试系统"的专利，公开号CN120029922A，申请日期为2025 年02月。 专利摘要显示，本申请提供了一种搜索软件的测试方法、装置和搜查软件测试系统，该方法包括：获取 搜索软件的原始测试用例，原始测试用例为测试搜索软件的搜索功能的测试用例；设置搜索软件的搜索 功能对应的蜕变关系，蜕变关系为搜索软件的搜索的输入和输出之间需要满足的关系；根据蜕变关系生 成原始测试用例的多个衍生测试用例，衍生测试用例的输入与原始测试用例的输入满足蜕变关系；根据 原始测试用例和多个衍生测试用例对搜索软件的搜索功能进行测试，得到原始测试用例的输出和各衍生 测 ...

Core Viewpoint - The draft revision of the Shandong Provincial Patent Regulations aims to enhance the protection of patent rights, adapt to new developments in intellectual property, and promote the transformation and application of patents in the region [3][4]. Group 1: Legislative Background - The original Shandong Provincial Patent Regulations were implemented in 2013, and the need for revision arises from changes in national patent laws and the evolving landscape of intellectual property [3]. - The revision is necessary to align with the latest legislative spirit regarding the protection of patent rights and the promotion of patent implementation and conversion [3][4]. Group 2: Key Changes in the Draft - The draft consists of 6 chapters and 53 articles, reducing the original structure from seven chapters to six, with significant updates to the content [5]. - New legislative goals include fostering new quality productivity and promoting high-quality economic and social development through comprehensive patent protection [5][6]. - The draft emphasizes the creation and protection of patents in new technologies, industries, and business models, including the promotion of artificial intelligence applications [5][6]. Group 3: Administrative Penalties - The draft introduces administrative penalties for three types of violations: aiding infringement, repeated infringement, and non-compliance with exhibition infringement rulings, with fines ranging from 5,000 to 100,000 yuan [7][8]. - Specific penalties include fines for providing support to infringing activities and for failing to comply with corrective measures during exhibitions [7][8]. Group 4: Overseas Patent Risk Management - The draft outlines the establishment of an overseas patent risk prevention system, addressing high costs and insufficient talent in dealing with international disputes [9]. - It emphasizes the government's role in supporting enterprises in overseas patent layout and enhancing their ability to respond to overseas patent disputes [9].

Group 1 - The core objective of the notification is to promote the industrialization of high-value patents and significantly increase the patent industrialization rate of universities and research institutions [1] - The National Intellectual Property Administration will focus on five areas: revitalizing existing patents in universities and research institutions, enhancing the competitive advantage of SMEs and key industries through patent industrialization, improving patent quality to promote industrialization, establishing long-term mechanisms for patent conversion and utilization, and ensuring the implementation of the special action [1] - Local authorities are encouraged to support industrial intellectual property operation centers and leading enterprises to analyze technology demands along the industry chain and organize targeted matching activities between patents and relevant institutions [1] Group 2 - The notification emphasizes the exploration of artificial intelligence to facilitate patent conversion and utilization, leveraging big data and AI technologies for effective matching [2] - It suggests using AI models for patent technology analysis, application scenario exploration, and enterprise technology demand data analysis to create diverse application scenarios for precise matching [2]

5月21日，国家知识产权局发布关于纵深推进专利转化运用专项行动加快形成长效机制的通知。其中提 出，加快培育一批专利产业化样板企业。各地要会同相关部门，向金融机构、区域性股权市场、科创基 金、公共服务机构、龙头企业等集中推送专利产业化样板企业培育库名单，组织实施技术需求对接、产 业化配套服务、投融资扶持等重点培育举措，引导产业链龙头企业吸纳具有"独门绝技"专利技术的入库 企业和专利密集型产品，进入产业链供应链，加强企业上市知识产权服务，加大对入库企业专利产业化 成长的支持力度。加快推动入库企业通过专利产业化，实现规模效益显著提升、形成专利密集型产品， 成为"小巨人"或者单项冠军，或者加快上市融资进程等，达到样板企业培育标准，实现快速成长目标。 国家知识产权局关于纵深推进专利转化运用专项行动加快形成长效机制的通知 2025年是专利转化运用专项行动的决战之年。各地要会同相关部门，紧扣《专利转化运用专项行动方案 （2023—2025年）》的目标任务，按照全国知识产权局局长会议和专利转化运用专项行动推进机制会议 的总体部署要求，攻坚克难、开拓创新，推动新一批高价值专利实现产业化，实现高校和科研机构专利 产业化率明显提高 ...

美国生物制药板块面临多重挑战，估值探底或现投资机会。 ①美联储隐秘购债变相QE 黄金与新兴市场或迎新机遇 美联储近日悄然买入436亿美元的美国国债，其中仅5月8日一天就购买了88亿美元的30年长期美债。尽 管美联储并未正式称这是QE（量化宽松），可能只是再投资到期债券本金，以避免资产负债表迅速缩 小，但分析认为这实则是一种"隐形宽松"。与此同时，全球央行购金需求强劲，3月全球央行购金64 吨，中国购买量达30吨。今年迄今全球央行的黄金需求月均达94吨，远超此前预计的80吨。此外，美联 储的这一操作可能还利好新兴市场，尤其是资源丰富的拉美经济体，iSharesMSCI巴西ETF和iShares拉 美40ETF今年已分别涨约25.10%和24.53%，分析称，这凸显战略性配置，旨在从美元走软与商品价格上 涨中受益。分析师认为，美联储的"隐秘动作"可能预示着市场将有大动作。黄金以及拉美市场的涨势可 能进一步加速。 评论员简佳：美联储的隐形宽松操作显示出其在当前复杂经济环境下的谨慎态度。通过悄无声息地买入 国债，美联储试图在不引起市场大幅波动的情况下，缓解资产负债表的快速缩小，为市场注入了流动 性。与此同时，全球央行 ...

（"金融赋能科技创新与发展"主题论坛，图片由主办方提供。） 深圳商报·读创客户端首席记者 谢惠茜 近日，为期两天的2025清华五道口全球金融论坛在深圳举办。近百位中外高级别政经领袖、重磅专家学者齐聚，展开 深入的思想碰撞与观点交锋，为全球经济金融的发展探寻新路径、注入新智慧。金融壹账通银行事业部总经理、中小 银行联盟秘书长贾燕菁出席该活动的第八个主题讨论会议，与重庆市原市长黄奇帆、国家科技成果转化引导基金理事 长马蔚华等嘉宾围绕会议主题"金融赋能科技创新与发展"共同探讨交流，分享真知灼见。 （金融壹账通银行事业部总经理、中小银行联盟秘书长贾燕菁，图片由主办方提供。） 面对上述痛点，贾燕菁提出"智能化实时风控、数据价值重构、专利估值"三位一体的金融机构服务科创企业策略框 架： 其次是数据资产的价值重构，企业丰富和庞大数据的有效积累，有助于金融机构的风险管理。例如，平安集团已构建 九大数据库，包括三大金融数据库（客户库、产品库、企业库），五大医疗数据库，一个公司经营库；金融、医疗数 据库包含30万亿字节数据，成为全球最大金融、医疗数据库之一。 再者是科创企业专利知识产权的有效沉淀，为金融机构对企业的估值，特别是破 ...

证券代码：871642 证券简称：通易航天 公告编号：2025-029 南通通易航天科技股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 二、 投资者关系活动情况 □特定对象调研 √业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 活动时间：2025 年 5 月 19 日 活动地点：本次业绩说明会采用网络远程的方式举行，投资者通过登陆上海 证券报官网中国证券网（https://roadshow.cnstock.com）参与。 参会单位及人员：通过网络方式参加公司 2024 年年度报告暨 2025 年第一季 度报告业绩说明会的投资者。 上市公司接待人员：公司董事长、总经理张欣戎先生；公司董事、董事会秘 书姜卫星先生；公司财务负责人周亚女士；公司保荐代表人安楠先生 三、 投资者关系活动主要内容 问题 1：公司新增多项专利，具体集中在哪些技术领域？是否有助于提升核 心业务的竞争力或开拓新市场？ 回复：尊敬的投资者，您 ...

Core Viewpoint - The U.S. large biopharmaceutical sector is currently facing significant challenges, leading to a notable underperformance compared to the S&P 500 index, with a gap of approximately 15 percentage points since a key tariff announcement on April 2, 2025 [1][15]. Group 1: Challenges Facing the Biopharmaceutical Sector - The sector is under pressure from multiple factors, including high tariff barriers, drug price negotiation pressures, and an impending patent cliff, creating a murky outlook for the industry [1][2]. - Morgan Stanley analysts categorize these challenges as "overhangs," which are structural issues that have been exacerbated by recent policy changes [2]. Group 2: Tariff and Supply Chain Challenges - Specific tariff policies have been a direct trigger for the recent downturn in the sector, creating significant uncertainty in the market [3]. - Morgan Stanley believes that the impact of tariffs is largely "manageable," with companies able to respond through inventory management and accelerated product shipments [3][5]. - The expected tax rate for companies heavily reliant on U.S. production may rise from approximately 16-17% to 19-20%, similar to Gilead Sciences [3]. Group 3: Drug Price Negotiation Pressures - Drug pricing remains a persistent concern, with the "Most Favored Nation" (MFN) pricing policy posing potential risks, although its widespread implementation faces significant hurdles [6][7]. - The Inflation Reduction Act (IRA) is expected to have an incremental rather than disruptive impact on market expectations regarding drug pricing [8]. - Setser's testimony highlights the disparity in profit reporting between U.S. and overseas operations, with U.S. companies reporting minimal profits domestically while generating substantial profits abroad [9][12]. Group 4: Patent Expiration and Valuation - The upcoming patent expirations for key drugs between 2028 and 2030 are anticipated to suppress sector valuations, but this is viewed as a manageable "profit reset" rather than a crisis [13][14]. - Historical data suggests that the average earnings per share (EPS) erosion following patent expirations is around 15%, with a subsequent rebound often occurring [14]. Group 5: Current Valuation and Market Sentiment - The biopharmaceutical sector's valuation has dropped to a historical low, with a relative discount of 45-50% compared to the S&P 500 index [15][18]. - The sector has seen an overall decline of about 8% since the tariff announcement, while the S&P 500 has increased by approximately 5% [18][20]. Group 6: Potential Catalysts for Recovery - Clarity in policy execution regarding tariffs, MFN, and IRA could alleviate investor concerns and potentially lead to a recovery in the sector [23]. - Setser's recommendations for tax reforms aimed at reducing profit and production outflows could fundamentally alter the industry's profit and production landscape [24]. - The removal of unfavorable terms in the IRA, such as the "pill penalty," could serve as a significant positive catalyst for the sector [23][25].

Group 1: Conference Overview - The 2025 China Automotive Intellectual Property Annual Conference was held in Wuhan from May 16-18, focusing on "Intelligent Initiation of a New Era in China's Intellectual Property and Creating a New Global Automotive Landscape" [1] - The conference was organized by the China Automotive Intellectual Property Utilization Promotion Center, with over 400 attendees from government, industry organizations, and enterprises [1] Group 2: Industry Innovation and Intellectual Property - The China Automotive Technology and Research Center emphasized its role as a state-owned enterprise in driving innovation and high-quality development in the automotive industry through intellectual property strategies [3] - Dongfeng Motor Corporation highlighted its commitment to high-level technological independence and collaboration with industry partners to build a comprehensive R&D system [3] Group 3: International Cooperation and Standards - The Deputy Director of the Intellectual Property Protection Department of the National Intellectual Property Administration urged Chinese automotive companies to engage in international intellectual property rule-making and cooperation [3] - The importance of standard essential patents (SEPs) was discussed, emphasizing their role in global negotiations and the need for fair licensing practices [7][10] Group 4: Challenges in Intellectual Property Management - Zhejiang Huayou Cobalt Industry pointed out the challenges in converting patents into competitive advantages, citing high management costs and the need for better integration of patent assets [5] - GAC Group's intellectual property expert stressed the necessity for companies to establish high-value patent cultivation systems to navigate the competitive automotive market [6] Group 5: AI and Intellectual Property - The integration of AI in the automotive industry was highlighted as a transformative force, with discussions on the implications of AI-generated content and the need for clear copyright policies [11][12] - The role of data in driving automotive innovation and the challenges related to data ownership and privacy were also addressed [13]